Leuko is improving quality of life and outcomes for chemotherapy patients and others at risk of severe neutropenia, through the first noninvasive white cell monitor.

Leuko

MIT is a world-class educational institution where teaching and research — with relevance to the practical world as a guiding principle — continue to be its primary purpose. MIT is independent, coeducational, and privately endowed. Its five schools and one college encompass numerous academic departments, divisions and degree-granting programs, as well as interdisciplinary centers, laboratories and programs whose work cuts across traditional departmental boundaries. Interested in applying? Visit the undergraduate or graduate admissions websites.

Find jobs at MIT startups!